PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Clinical Haematology, Guy\'s and St Thomas\' NHS Foundation Trust, London, UK.\', \'School of Cancer and Pharmaceutical Science, King\'s College London, London, UK.\', \'Department of Infectious Diseases, School of Immunology and Microbial Sciences, King\'s College London, London, UK.\', \'Department of Medicine and Molecular Genetics, King\'s College London, London, UK.\', \'Department of Haematological Medicine, King\'s College London School of Medicine, London, UK.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1111/bjh.17568
?:doi
?:hasPublicationType
?:journal
  • British journal of haematology
is ?:pmid of
?:pmid
?:pmid
  • 34085278
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.036
?:rankingScore_hIndex
  • 169
?:title
  • Single dose of BNT162b2 mRNA vaccine against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) induces neutralising antibody and polyfunctional T-cell responses in patients with chronic myeloid leukaemia.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all